ClinicalTrials.govpublic full text
FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel
squamous cell carcinoma of the head and neck, recurrent / metastatic scchn, frail patients, gortec, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873596
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.